董事会认为集团于本年度财务业绩显著改善乃主要由于以下各项的净影响，其中包括：(i)由于业务改 善，毛利同比增长约920万港元或184%;(ii)加强行政及营运开支的成本控制;(iii)于本年度，贷款资本化 收益约390万港元;及(iv)由于本年度的贷款资本化，融资成本减少。 国药科技股份(08156)公布截至2025年6月30日止年度业绩，收入约6130万港元，同比增加约48%。公司 拥有人应占亏损约90万港元，同比大幅减少约95%。每股亏损0.19港仙。 公告称，收入增长主要由于大健康产品市场需求增加及供应链服务营运效率提高，突显公司对该等核心 业务领域的战略重点的有效性。 ...

Core Viewpoint - The company, Tian Cai Holdings, is engaging in significant capital transactions involving its indirect non-wholly owned subsidiary, JSC, to enhance its operational capacity and financial stability in response to market conditions, particularly the U.S. tariff situation [1][3]. Group 1: Capital Injection and Share Issuance - On July 7, 2025, SL Vietnam, an indirect non-wholly owned subsidiary of the company, entered into a capital injection agreement with JSC, agreeing to subscribe for new shares representing 26.89% of JSC's total issued share capital as of the announcement date, with a total subscription price of $1,000,000 for general working capital [1]. - Following the completion of the capital injection, SL Imaging, a wholly-owned subsidiary, will also enter into a loan capitalization agreement with JSC, agreeing to subscribe for capitalized shares representing 54.38% of JSC's total issued share capital as of the announcement date, with a total issuance price of $11,000,000 to capitalize outstanding loan principal [1][3]. Group 2: Ownership Structure Post Transactions - After the completion of the capital injection and loan capitalization, SL Vietnam will enter into a purchase agreement to acquire shares from the seller, which will result in the company holding 99.45% of JSC's total issued share capital, with 69.45% held through SL Vietnam and 30.00% through SL Imaging [2]. - As of the announcement date, the group holds 73.70% of JSC's issued share capital, with the seller and independent third parties holding 25.31% and 0.99%, respectively [2]. Group 3: Financial Impact and Strategic Goals - The capital injection and loan capitalization are expected to improve JSC's capital structure and debt ratio, thereby enhancing its ability to expand production facilities and capacity in Vietnam amid U.S. tariff challenges [3].